I’m glad you’re excited about this idea. Making the business case to companies to take AI safety seriously, from an investor perspective, could be an important angle to getting more companies to take it seriously.
Not much difference between 1 and 100 shares. Influence certainly depends on number of shares, but it’s more dependent on credibility. There are a number of great examples of smaller investors with issue area expertise substantially affecting corporate operations. And other small investors have raised new issues from new angles to company management. More still have built coalitions, and garnered significant press. All pathways to impact.
I’m glad you’re excited about this idea. Making the business case to companies to take AI safety seriously, from an investor perspective, could be an important angle to getting more companies to take it seriously.
Not much difference between 1 and 100 shares. Influence certainly depends on number of shares, but it’s more dependent on credibility. There are a number of great examples of smaller investors with issue area expertise substantially affecting corporate operations. And other small investors have raised new issues from new angles to company management. More still have built coalitions, and garnered significant press. All pathways to impact.
James Gifford has done the best work on this, and the executive summary is especially worth a read: https://www.slideshare.net/slideshow/embed_code/key/E28F5ODb5Rk2tu (sorry it’s in a terrible format, that’s the only version I could find that’s not behind a pay wall).